HEALTHY EXTRACTS INC. (HYEX): Entry into a Material Definitive Agreement
HEALTHY EXTRACTS INC. (HYEX) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. On November 10, 2026, we entered into a Securities Purchase Agreement whereby we issued a Secured Promissory Note in the principal amount of $555,556 to HINTERLAND PARTNERS LLC, a Delaware limited liability company (the “Holde
- Instrument
- Secured Promissory Note
- Amount
- $555,556
- Interest rate
- thirteen percent (13%) per annum
- Lender
- HINTERLAND PARTNERS LLC
Facts are quoted from the filing text and checked against it. Details that could not be matched to the text are left out.
How this was made
The 30-second read
Why it matters
The disclosed structure combines secured downside protection for the holder with equity upside via conversion, while also imposing ongoing revenue-based royalty payments that can compress operating flexibility.
Market read
Traders may reassess HYEX’s dilution and cash-flow risk profile based on the fixed $2.00 conversion price, secured collateral, and monthly 12.5% gross revenue royalties.
What to watch
The security agreement terminates upon initial listing on a major US exchange tier, which may improve future refinancing optionality if HYEX is progressing toward that milestone.
Background
The filing is an SEC Form 8-K reporting entry into a Securities Purchase Agreement and related secured promissory note, plus an unregistered equity issuance exemption.
Ticker impact
Healthy Extracts disclosed a $555,556 secured note with 13% interest, monthly 12.5% revenue royalties, and conversion at $2.00 per share.
Likely downside pressure as traders price in dilution and recurring royalty obligations tied to gross revenue.
The 8-K details fixed conversion pricing, security interest in substantially all assets, and mandatory monthly royalty payments starting March 1, 2027, which are direct risk drivers for equity holders.
Market effects
Adds another example of small-cap financing using secured notes with conversion and revenue royalties, which can weigh on sentiment toward similar micro/small-cap issuers.
No direct regional market linkage beyond US small-cap credit/equity sentiment.
Limited, as the disclosure is company-specific and not tied to global macro or cross-border markets.
Counterpoint
The note includes a 90-day repayment window with waived accrued interest, which could reduce cost if the company can refinance quickly.
Key entities
- issuerHealthy Extracts Inc.
Company filing the 8-K and issuing the secured promissory note with conversion and royalty obligations.
- investorHinterland Partners LLC
Accredited holder receiving the secured note and security interest in substantially all assets.
- placement_agentCarter, Terry, & Company, Inc.
Placement agent referenced as receiving $30,000 from issuance proceeds withheld for fees.
